179 related articles for article (PubMed ID: 37669049)
41. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
Elife; 2023 Jun; 12():. PubMed ID: 37377399
[TBL] [Abstract][Full Text] [Related]
42. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province.
Decker KM; Feely A; Bucher O; Singh H; Turner D; Lambert P
Prev Med; 2022 Feb; 155():106961. PubMed ID: 35065173
[TBL] [Abstract][Full Text] [Related]
43. Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic.
Janczewski LM; Browner AE; Cotler JH; Palis BE; Chan K; Joung RH; Bentrem DJ; Merkow RP; Boffa DJ; Nelson H
JAMA Netw Open; 2024 Mar; 7(3):e240160. PubMed ID: 38441896
[TBL] [Abstract][Full Text] [Related]
44. Utilization of Physician-Based Mental Health Care Services Among Children and Adolescents Before and During the COVID-19 Pandemic in Ontario, Canada.
Saunders NR; Kurdyak P; Stukel TA; Strauss R; Fu L; Guan J; Fiksenbaum L; Cohen E; Guttmann A; Vigod S; Chiu M; Hepburn CM; Moran K; Gardner W; Cappelli M; Sundar P; Toulany A
JAMA Pediatr; 2022 Apr; 176(4):e216298. PubMed ID: 35129604
[TBL] [Abstract][Full Text] [Related]
45. During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in England.
Lemanska A; Andrews C; Fisher L; Bacon S; Mehrkar A; Inglesby P; Davy S; Goldacre B; MacKenna B; ; Walker AJ
BJU Int; 2024 May; 133(5):587-595. PubMed ID: 38414224
[TBL] [Abstract][Full Text] [Related]
46. Delay and Disparity in Observed vs Predicted Incidence Rate of Screenable Cancer During the COVID-19 Pandemic.
Romatoski KS; Chung SH; Kenzik K; Rasic G; Ng SC; Tseng JF; Sachs TE
J Am Coll Surg; 2023 Sep; 237(3):420-430. PubMed ID: 37227063
[TBL] [Abstract][Full Text] [Related]
47. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
48. Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID-19 pandemic's impact on cancer diagnosis.
Negoita S; Chen HS; Sanchez PV; Sherman RL; Henley SJ; Siegel RL; Sung H; Scott S; Benard VB; Kohler BA; Jemal A; Cronin KA
Cancer; 2024 Jan; 130(1):117-127. PubMed ID: 37755665
[TBL] [Abstract][Full Text] [Related]
49. Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic.
Luo H; Lau WCY; Chai Y; Torre CO; Howard R; Liu KY; Lin X; Yin C; Fortin S; Kern DM; Lee DY; Park RW; Jang JW; Chui CSL; Li J; Reich C; Man KKC; Wong ICK
JAMA Psychiatry; 2023 Mar; 80(3):211-219. PubMed ID: 36696128
[TBL] [Abstract][Full Text] [Related]
50. Whole-population trends in pathology-confirmed cancer incidence in Northern Ireland, Scotland and Wales during the SARS-CoV-2 pandemic: A retrospective observational study.
Greene GJ; Thomson CS; Donnelly D; Chung D; Bhatti L; Gavin AT; Lawler M; Huws DW; Rolles MJ; Bennée F; Morrison DS
Cancer Epidemiol; 2023 Jun; 84():102367. PubMed ID: 37119604
[TBL] [Abstract][Full Text] [Related]
51. Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
Viana Veloso GG; Amaral FD; Nogueira-Rodrigues A
BMC Cancer; 2024 Apr; 24(1):539. PubMed ID: 38679710
[TBL] [Abstract][Full Text] [Related]
52. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
[TBL] [Abstract][Full Text] [Related]
53. The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis.
Popovic M; Fiano V; Moirano G; Chiusa L; Conway DI; Garzino Demo P; Gilardetti M; Iorio GC; Moccia C; Ostellino O; Pecorari G; Ramieri G; Ricardi U; Riva G; Virani S; Richiardi L
Front Public Health; 2022; 10():809283. PubMed ID: 35265573
[TBL] [Abstract][Full Text] [Related]
54. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
[TBL] [Abstract][Full Text] [Related]
55. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
[TBL] [Abstract][Full Text] [Related]
56. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
58. Association of Recent SARS-CoV-2 Infection With New-Onset Alcohol Use Disorder, January 2020 Through January 2022.
Olaker VR; Kendall EK; Wang CX; Parran TV; Terebuh P; Kaelber DC; Xu R; Davis PB
JAMA Netw Open; 2023 Feb; 6(2):e2255496. PubMed ID: 36757694
[TBL] [Abstract][Full Text] [Related]
59. Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States.
Burney JA; Roberts SC; DeHaan LL; Shimizu C; Bainto EV; Newburger JW; Dominguez S; Jone PN; Jaggi P; Szmuszkovicz JR; Rowley AH; Samuy N; Scalici P; Tremoulet AH; Cayan DR; Burns JC;
JAMA Netw Open; 2022 Jun; 5(6):e2217436. PubMed ID: 35713905
[TBL] [Abstract][Full Text] [Related]
60. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
